STRATEGIC MARKET ACCESS FOR GLOBAL PHARMACEUTICAL BIOTECHNOLOGY,
DIAGNOSTICS TEST AND MEDICAL DEVICE COMPANIES, INCLUDING:
- Organizational design of structure and processes for market access or health economics research capability
- Integration of market access/health economics capability with product development and commercialization teams, to optimize its value to the organization
- Development of department strategic plans for market access/health economic research
- Development of product plans for strategic market access, including health economics and outcomes research, publication and communication strategies
- Development of risk-sharing programs to complement market access strategies
- Commercial portfolio assessments, with a focus on optimizing pricing and reimbursement
- Pricing and reimbursement opportunity assessments for products in early and late stage development programs, including assessment of pricing and reimbursement assumptions in product forecasts
- Organization and facilitation of advisory boards for global market access or health economics and outcomes research
- Company-wide training and communication on market access and the value of the market access capability
